Delivery Order SPE2DB22D2206-SPE2DB25FJA74
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $7,564.32. The contract is scheduled for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $25,379 delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical products for use by the Department of Defense from its facility in Conshohocken, Pennsylvania. The firm fixed price contract runs from August 15, 2023 to September 6, 2023 and was issued under an existing DLA pharmaceutical supply vehicle. No...
- The Defense Logistics Agency Troop Support Medical awarded a $10,152 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. The place of performance is Conshohocken, Pennsylvania. The contract period runs from July 25, 2023 through August 15, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,789.25, is for the delivery of Zoladex 10.8 mg implant syringes, a medication used for the treatment of certain medical conditions. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and...
- The Defense Logistics Agency awarded a $1,692 delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from September 27 to October 19, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,631.84, is for the delivery of Zoladex 10.8 mg implant syringes. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of July 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of the pharmaceutical product Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a potential ceiling value of $5,445.66. The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 30, 2024. AmerisourceBergen...
- The Defense Logistics Agency awarded a $15,227 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the implants to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA contract vehicle and has a period of performance from June 22, 2023 through July 14, 2023. No set aside designation or subcontractors were identified....
- This federal contract award is for the delivery of Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA). The contract, valued at $16,919.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of February 9, 2023. While the original solicitation was not provided, the award indicates that no set-aside was used, suggesting open...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA74Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes valued at $5,578.50 with a firm fixed price contract type. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside competitive award, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract running through December 2026 that enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The Zoladex implant delivery fulfills military healthcare system requirements through AmerisourceBergen's established capability to meet federal procurement standards in competitive procurement environments and deliver specialized pharmaceutical products efficiently to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/23/25 |